Exploring pharmacists' perspectives about substandard and falsified medical products through interviews

被引:0
|
作者
Persson, A. [1 ]
Troein, M. [1 ]
Lundin, S. [2 ]
Midlov, P. [1 ]
Lenander, C. [1 ]
机构
[1] Lund Univ, Ctr Primary Hlth Care Res, Dept Clin Sci Malmo, Box 50332, SE-20213 Malmo, Sweden
[2] Lund Univ, Dept Arts & Cultural Sci, LUX Helgonavagen 3, SE-22100 Lund, Sweden
关键词
Public health; Drug -related side -effects and adverse reactions; Qualitative research; Substandard falsified medical products; Pharmacists; Professional -patient relations; PATERNALISM;
D O I
10.1016/j.rcsop.2024.100421
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: The problem with substandard and falsified (SF) medical products may grow in high-income countries when e-commerce of medicines increases. Unauthorized websites offer medicines of insufficient quality. This underscores the importance of evaluating how the problem with SF medical products can be prevented from escalating. However, little is known about what knowledge and experience professionals working primarily with medicines have about the phenomenon. Objective: This study was conducted to explore purposively selected pharmacists' experience and knowledge about SF medical products. Methods: Twelve individual interviews were conducted with purposively selected pharmacists between May 2021 and September 2021. An interview guide was used with specific questions about e-commerce, which focused on exploring pharmacists' experience and knowledge about SF medical products. The interviews lasted, on average, 49 min and were analyzed using inductive qualitative content analysis. Results: A main theme 'Pharmacists as guardians of safe medicines' emerged. This theme consisted of three categories pinpointing 'risk factors', 'protective factors', and 'opportunities for improvement' regarding SF medical products. Findings suggest that pharmacists can play a role in preventing the problem with SF medical products from escalating. Participants emphasized they were in this line of work to help patients and increase patient safety. Conclusions: Pharmacists have the opportunity to empower the public with knowledge about SF medical products since they discuss medicines with many people every day. Awareness of risk factors for SF medical products enables pharmacists to guide patients to avoid risky purchases from unauthorized websites. To do this, better communication, and cooperation with patients and other healthcare professionals are needed.
引用
收藏
页数:6
相关论文
共 26 条
  • [1] Substandard and falsified medical products: bibliometric analysis and mapping of scientific research
    Waleed M. Sweileh
    Globalization and Health, 17
  • [2] Substandard and falsified medical products: bibliometric analysis and mapping of scientific research
    Sweileh, Waleed M.
    GLOBALIZATION AND HEALTH, 2021, 17 (01)
  • [3] Substandard and Falsified Medical Products: A Global Issue Affecting the Health of Women and Children
    Callister, Lynn Clark
    MCN-THE AMERICAN JOURNAL OF MATERNAL-CHILD NURSING, 2019, 44 (06) : 361 - 361
  • [4] The scourge of substandard and falsified medical products gets worse with COVID-19 pandemic
    Shiferie, Fisseha
    Kassa, Eden
    PAN AFRICAN MEDICAL JOURNAL, 2020, 37 : 344
  • [5] Collaborative Stakeholders approach in Combating Substandard and Falsified Medical Products in Indonesia: A Qualitative Study
    Handayani, Retty Dwi
    Purwadianto, Agus
    Magenda, Burhan Djabir
    3RD BIOMEDICAL ENGINEERING'S RECENT PROGRESS IN BIOMATERIALS, DRUGS DEVELOPMENT, AND MEDICAL DEVICES, 2019, 2092
  • [6] The response to substandard and falsified medical products in francophone sub-Saharan African countries: weaknesses and opportunities
    Mace, Cecile
    Nikiema, Jean-Baptiste
    Sarr, Omar Serigne
    Ciza Hamuli, Patient
    Marini, Roland Djang'eing'a
    Neci, Richard Cizungu
    Bourdillon Esteve, Pernette
    Ravinetto, Raffaella
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2023, 16 (01)
  • [7] Health alerts for substandard, falsified, and unregistered medical products at the onset of the COVID-19 pandemic in the Americas
    Gorordo, Marisa
    Rojas-Cortes, Robin
    Carino, Jesica
    Zambrano, Juanita Vahos
    Castro, Jose Luis
    REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2024, 48
  • [8] The response to substandard and falsified medical products in francophone sub-Saharan African countries: weaknesses and opportunities
    Cécile Macé
    Jean-Baptiste Nikiema
    Omar Serigne Sarr
    Patient Ciza Hamuli
    Roland Djang’eing’a Marini
    Richard Cizungu Neci
    Pernette Bourdillon Esteve
    Raffaella Ravinetto
    Journal of Pharmaceutical Policy and Practice, 16
  • [9] Can public education campaigns equitably counter the use of substandard and falsified medical products in African countries?
    Wagnild, Janelle M.
    Owusu, Samuel Asiedu
    Mariwah, Simon
    Kolo, Victor, I
    Vandi, Ahmed
    Namanya, Didacus Bambaiha
    Kuwana, Rutendo
    Jayeola, Babatunde
    Prah-Ashun, Vigil
    Adeyeye, Moji Christianah
    Komeh, James
    Nahamya, David
    Hampshire, Kate
    HEALTH POLICY AND PLANNING, 2025,
  • [10] Improved knowledge on substandard and falsified (SF) medical products through a dedicated course for pharmacy students at three universities in sub-Saharan Africa
    Kusynova, Zuzana
    Bais, Youssra
    van den Ham, Hendrika A.
    Mantel-Teeuwisse, Aukje K.
    Etame-Loe, Gisele
    Kaale, Eliangiringa
    Sarr, Serigne Omar
    Guiet-Mati, Fatima
    Bourdillon-Esteve, Pernette
    BMJ GLOBAL HEALTH, 2023, 6 (SUPPL_3):